Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Non drug-related and opioid-specific causes of 3262 deaths in Scotland's methadone-prescription clients, 2009-2015.

Gao L, Robertson JR, Bird SM.

Drug Alcohol Depend. 2019 Apr 1;197:262-270. doi: 10.1016/j.drugalcdep.2019.01.019. Epub 2019 Feb 19.

2.

Ageing opioid users' increased risk of methadone-specific death in the UK.

Pierce M, Millar T, Robertson JR, Bird SM.

Int J Drug Policy. 2018 May;55:121-127. doi: 10.1016/j.drugpo.2018.02.005. Epub 2018 Mar 21.

3.

External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial.

Bird SM, Strang J, Ashby D, Podmore J, Robertson JR, Welch S, Meade AM, Parmar MKB.

Contemp Clin Trials Commun. 2017 Mar;5:100-106. doi: 10.1016/j.conctc.2017.01.006.

4.

Risk-factors for methadone-specific deaths in Scotland's methadone-prescription clients between 2009 and 2013.

Gao L, Dimitropoulou P, Robertson JR, McTaggart S, Bennie M, Bird SM.

Drug Alcohol Depend. 2016 Oct 1;167:214-23. doi: 10.1016/j.drugalcdep.2016.08.627. Epub 2016 Aug 29.

5.

Responding to illicit drug use in family practice.

Robertson JR, Robertson AR.

Curr Opin Psychiatry. 2015 Jul;28(4):286-91. doi: 10.1097/YCO.0000000000000174. Review.

PMID:
26001919
6.

Mortality related to novel psychoactive substances in Scotland, 2012: an exploratory study.

McAuley A, Hecht G, Barnsdale L, Thomson CS, Graham L, Priyadarshi S, Robertson JR.

Int J Drug Policy. 2015 May;26(5):461-7. doi: 10.1016/j.drugpo.2014.10.010. Epub 2014 Nov 10.

PMID:
25477285
7.

Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancer.

Karnak D, Engelke CG, Parsels LA, Kausar T, Wei D, Robertson JR, Marsh KB, Davis MA, Zhao L, Maybaum J, Lawrence TS, Morgan MA.

Clin Cancer Res. 2014 Oct 1;20(19):5085-96. doi: 10.1158/1078-0432.CCR-14-1038. Epub 2014 Aug 12.

8.

Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776.

Engelke CG, Parsels LA, Qian Y, Zhang Q, Karnak D, Robertson JR, Tanska DM, Wei D, Davis MA, Parsels JD, Zhao L, Greenson JK, Lawrence TS, Maybaum J, Morgan MA.

Clin Cancer Res. 2013 Aug 15;19(16):4412-21. doi: 10.1158/1078-0432.CCR-12-3748. Epub 2013 Jun 26.

9.

Early life influences on the risk of injecting drug use: case control study based on the Edinburgh Addiction Cohort.

Macleod J, Hickman M, Jones HE, Copeland L, McKenzie J, De Angelis D, Kimber J, Robertson JR.

Addiction. 2013 Apr;108(4):743-50. doi: 10.1111/add.12056. Epub 2012 Dec 21.

PMID:
23163301
10.

Methadone replacement therapy: tried, tested, effective?

Robertson JR, Daniels AM.

J R Coll Physicians Edinb. 2012 Jun;42(2):133-8. doi: 10.4997/JRCPE.2012.210.

PMID:
22693699
11.

My mentors in urogynecology.

Robertson JR, Drutz HP.

Int Urogynecol J. 2011 Oct;22(10):1209-10. doi: 10.1007/s00192-011-1475-3. Epub 2011 Jul 28. No abstract available.

PMID:
21796473
12.

Avian use of perennial biomass feedstocks as post-breeding and migratory stopover habitat.

Robertson BA, Doran PJ, Loomis ER, Robertson JR, Schemske DW.

PLoS One. 2011 Mar 3;6(3):e16941. doi: 10.1371/journal.pone.0016941.

13.

Cannabis and the lung.

Reid PT, Macleod J, Robertson JR.

J R Coll Physicians Edinb. 2010 Dec;40(4):328-3; quiz 333-4. doi: 10.4997/JRCPE.2010.417. Review.

PMID:
21132143
14.

Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.

Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, Robertson JR.

BMJ. 2010 Jul 1;341:c3172. doi: 10.1136/bmj.c3172.

15.

Changes in the inequality of mental health: suicide in Australia, 1907-2003.

Doessel DP, Williams RF, Robertson JR.

Health Econ Policy Law. 2011 Jan;6(1):23-42. doi: 10.1017/S1744133110000101. Epub 2010 Apr 20.

PMID:
20403233
16.

The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls.

Macleod J, Copeland L, Hickman M, McKenzie J, Kimber J, De Angelis D, Robertson JR.

BMC Public Health. 2010 Feb 26;10:101. doi: 10.1186/1471-2458-10-101.

17.

Commentary on Senn et al. (2009): primary care is the place to manage hepatitis C in opiate-dependent patients.

Robertson JR.

Addiction. 2009 Dec;104(12):2039-40. doi: 10.1111/j.1360-0443.2009.02822.x. No abstract available.

PMID:
19922571
18.

Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.

Robertson JR, Raab GM, Bruce M, McKenzie JS, Storkey HR, Salter A.

Addiction. 2006 Dec;101(12):1752-9.

PMID:
17156174
19.

Changes in opiate treatment during attendance at a community drug service--findings from a clinical audit.

Macleod J, Whittaker A, Robertson JR.

Drug Alcohol Rev. 1998 Mar;17(1):19-25.

PMID:
16203465
20.

Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001.

Copeland L, Budd J, Robertson JR, Elton RA.

Arch Intern Med. 2004 Jun 14;164(11):1214-20.

PMID:
15197047
21.

Effects of a magnetic field on pelvic floor muscle function in women with stress urinary incontinence.

Bergman J, Robertson JR, Elia G.

Altern Ther Health Med. 2004 May-Jun;10(3):70-2.

PMID:
15154155
22.

Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S; European and Italian Seroconverter Studies.

J Infect Dis. 2004 Jan 15;189(2):292-302. Epub 2004 Jan 8.

PMID:
14722895
23.

Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level.

van Asten LC, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Hernández Aguado I, McMenamin J, Zangerle R, Fontanet A, Coutinho RA, Prins M.

Eur J Public Health. 2003 Dec;13(4):347-9.

PMID:
14703322
24.

Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion.

van Asten L, Langendam M, Zangerle R, Hernández Aguado I, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Fontanet A, Coutinho RA, Prins M.

AIDS. 2003 May 23;17(8):1201-8.

PMID:
12819522
25.

Teebi hypertelorism syndrome: report of a family with previously unrecognized findings.

Tsai AC, Robertson JR, Teebi AS.

Am J Med Genet. 2002 Dec 1;113(3):302-6.

PMID:
12439902
26.

Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission.

Lockett SF, Robertson JR, Brettle RP, Yap PL, Middleton D, Leigh Brown AJ.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):277-80.

PMID:
11464148
27.

The analysis of methadone in nail clippings from patients in a methadone-maintenance program.

Lemos NP, Anderson RA, Robertson JR.

J Anal Toxicol. 2000 Oct;24(7):656-60.

PMID:
11043676
28.

New British guidelines on the clinical management of drug misuse and drug dependence.

Robertson JR.

Addiction. 2000 Mar;95(3):325-6. No abstract available.

PMID:
10795347
29.

Do gender differences in CD4 cell counts matter?

Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A.

AIDS. 1999 Dec 3;13(17):2361-4.

PMID:
10597777
30.

Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.

Lockett SF, Alonso A, Wyld R, Martin MP, Robertson JR, Gore SM, Leen CL, Brettle RP, Yirrell DL, Carrington M, Brown AJ.

J Infect Dis. 1999 Sep;180(3):614-21.

PMID:
10438347
31.

Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?

Prins M, Brettle RP, Robertson JR, Hernández Aguado I, Broers B, Carré N, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A.

Int J Epidemiol. 1999 Jun;28(3):541-9.

PMID:
10405862
32.

Nail analysis for drugs of abuse: extraction and determination of cannabis in fingernails by RIA and GC-MS.

Lemos NP, Anderson RA, Robertson JR.

J Anal Toxicol. 1999 May-Jun;23(3):147-52.

PMID:
10369322
33.

Characteristics of patients less than 45 years of age compared with older patients undergoing coronary artery bypass grafting.

Nguyen TD, de Virgilio C, Kakuda J, Omari BO, Milliken JC, Robertson JR, Baumgartner FJ.

Clin Cardiol. 1998 Dec;21(12):913-6.

34.

Heterosexual transmission of HIV in men and women in a Scottish cohort.

Robertson JR, Wyld R, Elton R, Brettle RP.

AIDS. 1998 May 7;12(7):823-4. No abstract available.

PMID:
9619819
35.

Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.

Prins M, Hernández Aguado IH, Brettle RP, Robertson JR, Broers B, Carré N, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A.

AIDS. 1997 Nov 15;11(14):1747-56.

PMID:
9386810
36.

Has the rate of progression to AIDS changed in recent years?

Carré N, Prins M, Meyer L, Brettle RP, Robertson JR, McArdle H, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A.

AIDS. 1997 Nov;11(13):1611-8.

PMID:
9365766
37.

Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals.

Wyld R, Robertson JR, Brettle RP, Mellor J, Prescott L, Simmonds P.

J Infect. 1997 Sep;35(2):163-6.

PMID:
9354351
38.

The molecular epidemiology of human immunodeficiency virus type 1 in six cities in Britain and Ireland.

Brown AJ, Lobidel D, Wade CM, Rebus S, Phillips AN, Brettle RP, France AJ, Leen CS, McMenamin J, McMillan A, Maw RD, Mulcahy F, Robertson JR, Sankar KN, Scott G, Wyld R, Peutherer JF.

Virology. 1997 Aug 18;235(1):166-77.

39.

Methadone treatment. Methadone treatment is not the only option.

Robertson JR, Macleod J.

BMJ. 1996 Dec 7;313(7070):1480-1. No abstract available.

40.

Cannabis use in the community.

Robertson JR, Miller P, Anderson R.

Br J Gen Pract. 1996 Nov;46(412):671-4.

41.

The war on drugs. Harm minimisation is a way of lessening effects of more harmful drugs.

Robertson JR.

BMJ. 1996 Mar 9;312(7031):636. No abstract available.

42.

Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease.

McNeil AJ, Yap PL, Gore SM, Brettle RP, McColl M, Wyld R, Davidson S, Weightman R, Richardson AM, Robertson JR.

QJM. 1996 Mar;89(3):177-85.

PMID:
8731561
44.

Heterosexual transmission of HIV analysed by generalized estimating equations.

Fielding KL, Brettle RP, Gore SM, O'Brien F, Wyld R, Robertson JR, Weightman R.

Stat Med. 1995 Jun 30;14(12):1365-78.

PMID:
7569494
45.

Schizophrenia with karyotype mosaic 47,XXY/48,XXY + 8.

Ong SH, Robertson JR.

Psychiatr Genet. 1995 Summer;5(2):67-9.

PMID:
7551965
46.

Treatment for drug dependence.

Robertson JR.

Lancet. 1994 Dec 10;344(8937):1640. No abstract available.

PMID:
7984015
47.

Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years.

Robertson JR, Ronald PJ, Raab GM, Ross AJ, Parpia T.

BMJ. 1994 Aug 6;309(6951):369-72.

48.

Misuse of benzodiazepines. Drug users will shift to another preparation.

Robertson JR.

BMJ. 1994 Jun 25;308(6945):1709. No abstract available.

49.

Benzodiazepine super-abuse.

Robertson JR.

Br J Gen Pract. 1994 Jun;44(383):282. No abstract available.

50.

HIV testing and prevalence in pregnancy in Edinburgh.

Johnstone FD, Brettle RP, Burns SM, Peutherer J, Mok JY, Robertson JR, Hamilton B, Tappin DM.

Int J STD AIDS. 1994 Mar-Apr;5(2):101-4.

PMID:
8031909

Supplemental Content

Loading ...
Support Center